文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer.

作者信息

Chang Hung-Pin, Sun Jen-Tang, Cheng Chiao-Yin, Liang Yao-Jen, Chen Yen-Lin

机构信息

Department of Emergency Medicine, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.

Graduate Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei City 242, Taiwan.

出版信息

Life (Basel). 2022 May 9;12(5):709. doi: 10.3390/life12050709.


DOI:10.3390/life12050709
PMID:35629376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9146826/
Abstract

The prognosis of advanced gastric cancer remains poor. Overexpression of high mobility group A 1 (HMGA1) in breast cancer and neuroblastoma indicates a poor prognosis. However, the relationship between HMGA1 expression and gastric cancer development remains unclear. Treatment strategies can be developed by identifying potential markers associated with gastric cancer. We used a constructed tissue array and performed hematoxylin and eosin and immunohistochemical staining. We quantified the staining results and performed statistical analysis to evaluate the relationship between HMGA1 expression and prognosis. HMGA1 expression was related to the expression of Ki-67, caspase3, CD31, N-cadherin, fibronectin, pAkt, and pErk. In the Kaplan-Meier graph, higher HMGA1 expression levels were associated with a relatively poor survival rate ( = 0.04). High expression of HMGA1 leads to a low survival rate, which is associated with HMGA1, proliferation, apoptosis, angiogenesis, epithelial-mesenchymal transition, and tyrosine kinase.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/e18cf2b77cdb/life-12-00709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/6d4248e6b0ec/life-12-00709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/b789c00b954c/life-12-00709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/e18cf2b77cdb/life-12-00709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/6d4248e6b0ec/life-12-00709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/b789c00b954c/life-12-00709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb2/9146826/e18cf2b77cdb/life-12-00709-g003.jpg

相似文献

[1]
High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer.

Life (Basel). 2022-5-9

[2]
Asiaticoside Suppresses Gastric Cancer Progression and Induces Endoplasmic Reticulum Stress through the miR-635/HMGA1 Axis.

J Immunol Res. 2022

[3]
High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.

Cancer. 2008-7-15

[4]
Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.

Mol Cell Biochem. 2015-6

[5]
Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer.

Oncol Lett. 2017-11

[6]
HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer.

Dis Markers. 2022

[7]
HMGA1 Has Predictive Value in Response to Chemotherapy in Gastric Cancer.

Curr Oncol. 2021-12-23

[8]
HMGA1 accelerates the malignant progression of gastric cancer through stimulating EMT.

Eur Rev Med Pharmacol Sci. 2020-4

[9]
Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.

Mol Cell Proteomics. 2016-1

[10]
HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.

Int J Surg. 2015-10-30

引用本文的文献

[1]
HMGA1 as a prognostic biomarker for gliomas: expression patterns, survival correlations, and clinical insights from a Pakistani cohort.

J Neurooncol. 2025-4-28

[2]
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer.

World J Gastroenterol. 2023-2-14

[3]
MCRS1 Expression Regulates Tumor Activity and Affects Survival Probability of Patients with Gastric Cancer.

Diagnostics (Basel). 2022-6-20

本文引用的文献

[1]
Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical Cancer by Regulating hsa-mir-296-5p/HMGA1.

J Immunol Res. 2021

[2]
Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy.

J Coll Physicians Surg Pak. 2021-5

[3]
Predictive Value of Combined Preoperative Carcinoembryonic Antigen Level and Ki-67 Index in Patients With Gastric Neuroendocrine Carcinoma After Radical Surgery.

Front Oncol. 2021-3-2

[4]
A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells.

Front Oncol. 2021-1-25

[5]
Serum CXCL13 and PECAM-1 can be used as diagnostic and prognostic markers in elderly patients with gastric cancer.

Clin Transl Oncol. 2021-1

[6]
HMGA1 accelerates the malignant progression of gastric cancer through stimulating EMT.

Eur Rev Med Pharmacol Sci. 2020-4

[7]
Comparison of the efficiency of transgelin, smooth muscle myosin, and CD31 antibodies for the assessment of vascular tumor invasion and free tumor deposits in gastric, pancreatic, and colorectal adenocarcinomas.

Indian J Pathol Microbiol. 2020

[8]
Clinical Implications of Extracellular HMGA1 in Breast Cancer.

Int J Mol Sci. 2019-11-26

[9]
The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers.

Biomed Res Int. 2019-10-13

[10]
Burden of Gastric Cancer.

Clin Gastroenterol Hepatol. 2020-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索